Analyst Price Targets — HYFM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 3, 2023 8:55 am | — | Wells Fargo | $1.50 | $1.51 | Benzinga | Wells Fargo Maintains Equal-Weight on Hydrofarm Holdings Group, Lowers Price Target to $1.5 |
| October 3, 2022 7:45 am | — | Wells Fargo | $2.00 | $1.94 | Benzinga | Wells Fargo Maintains Equal-Weight on Hydrofarm Holdings Group, Lowers Price Target to $2 |
| August 3, 2022 7:36 am | — | Wells Fargo | $2.50 | $3.27 | Benzinga | Wells Fargo Maintains Equal-Weight on Hydrofarm Holdings Group, Lowers Price Target to $2.5 |
| June 22, 2022 7:10 am | — | Wells Fargo | $4.00 | $4.26 | Benzinga | Wells Fargo Maintains Equal-Weight on Hydrofarm Holdings Group, Lowers Price Target to $4 |
Latest News for HYFM
Even with legal cannabis growing in acceptance, it is still a highly volatile market. This means that most publicly traded cannabis companies exhibit unpredictable trading patterns. Now, all sectors of the stock market face volatility; it's just that the cannabis sector sees a significant portion of it. However, volatility has not stopped investors from making a profit.
Marijuana stocks are still facing a battle in the stock market. The cannabis sector has been fighting to reach higher trading levels more consistently. For some time, there has been significant volatility that has been somewhat challenging for shareholders. You would think that with legal operators showing profitability and overall success, it would follow for the public sector. However, this has not been the case…
The cannabis sector continues to evolve as 2026 begins. While plant-touching operators still face regulatory pressure, ancillary companies remain better positioned. These businesses do not grow or sell cannabis directly. Instead, they provide the tools, products, and infrastructure that the industry depends on. As a result, they often carry less regulatory risk. They also tend to survive market downturns more…
The cannabis industry continues to evolve as operators adjust to tighter capital markets and shifting regulations. As a result, many investors are looking beyond plant-touching companies. Ancillary cannabis stocks often provide that alternative exposure. These businesses support the industry without directly selling cannabis. Therefore, they avoid many regulatory and licensing risks. At the same time, they still…
The cannabis industry continues evolving as legalization slowly expands across the United States. While plant-touching operators face regulatory and margin pressures, ancillary cannabis companies offer a different opportunity. These businesses sell products and services supporting cannabis cultivation without handling the plant itself. As a result, they often face fewer regulatory hurdles. In January 2026, several…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for HYFM.
U.S. House Trading
No House trades found for HYFM.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.